Status:
NOT_YET_RECRUITING
Effect of a Cepham Supplement on Hot Flashes and Menopausal Symptoms in Postmenopausal Women
Lead Sponsor:
Jacksonville University
Conditions:
D008593
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if a daily nutritional supplement can reduce hot flashes and other menopausal symptoms in postmenopausal women. The main questions this study aims to answe...
Detailed Description
Purpose: To evaluate the effectiveness of a nutritional supplement in reducing hot flash severity/frequency and menopausal symptoms in postmenopausal women. Design: Randomized, double-blind, placeb...
Eligibility Criteria
Inclusion
- Adult women aged 40-60 years.
- Menopause Rating Scale score: (a) GE 14 and (b) score of 3 or 4 (severe to very severe) for hot flashes (Blumel et al., 2018).
Exclusion
- Current use of hormone therapy or other medications known to affect hot flashes.
- Significant comorbidities that may interfere with study participation.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06939868
Start Date
May 1 2025
End Date
September 30 2025
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacksonville University
Jacksonville, Florida, United States, 32211